| Literature DB >> 35679588 |
Kevin P Kelly1, Hugo Borsetti1, Marta E Wenzler2, Alessandro Ustione3, Kwangho Kim2,4, Plamen P Christov4, Bianca Ramirez2, Joshua A Bauer4,5, David W Piston3, Carl Hirschie Johnson1,4, Gary A Sulikowski2,4.
Abstract
A high-throughput cell-based screen identified redox-active small molecules that produce a period lengthening of the circadian rhythm. The strongest period lengthening phenotype was induced by a phenazine carboxamide (VU661). Comparison to two isomeric benzquinoline carboxamides (VU673 and VU164) shows the activity is associated with the redox modulating phenazine functionality. Furthermore, ex vivo cell analysis using optical redox ratio measurements shows the period lengthening phenotype to be associated with a shift to the NAD/FAD oxidation state of nicotinamide and flavine coenzymes.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35679588 PMCID: PMC9398883 DOI: 10.1021/acschembio.2c00240
Source DB: PubMed Journal: ACS Chem Biol ISSN: 1554-8929 Impact factor: 4.634